Gianfranco Di Gennaro Selected Research

Gianfranco Di Gennaro Research Topics

2	COVID-19 06/2023 - 03/2022
2	Diphtheria 01/2023 - 01/2023
2	Tetanus 01/2023 - 01/2023
2	Neoplasms (Cancer) 01/2021 - 05/2016
2	Glioblastoma (Glioblastoma Multiforme) 01/2021 - 05/2016
2	Glioma (Gliomas) 01/2018 - 05/2016
1	Epilepsy (Aura) 12/2023
1	Nervous System Diseases (Neurological Disorders) 07/2023
1	Absence Epilepsy (Childhood Absence Epilepsy) 07/2023
1	Seizures (Absence Seizure) 07/2023
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 03/2023
1	Whooping Cough (Pertussis) 01/2023
1	Rubella (German Measles) 01/2023
1	Measles 01/2023
1	Human Influenza (Influenza) 01/2023
1	Mumps 01/2023
1	Vaccine-Preventable Diseases 01/2023
1	Molar Hypomineralization 09/2022
1	Developmental Defects of Enamel 09/2022
1	Mental Disorders (Mental Disorder) 03/2022
1	Gliosis 01/2022
1	Cognitive Dysfunction 01/2022
1	Neurocognitive Disorders (Clerambault Syndrome) 01/2022
1	Autism Spectrum Disorder 04/2021
1	Infections 01/2021

2	VaccinesIBA 01/2023 - 01/2023
2	AntigensIBA 01/2023 - 01/2023
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 05/2016
2	MicroRNAs (MicroRNA)IBA 01/2018 - 05/2016
1	Lacosamide FDA Link 12/2023
1	perampanelIBA 12/2023
1	brivaracetamIBA 12/2023
1	eslicarbazepine acetateIBA 12/2023
1	2- acetyl- 1- (4'- chlorophenyl)- 6,7- dimethoxy- 1,2,3,4- tetrahydroisoquinolineIBA 07/2023
1	alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)IBA 07/2023
1	Riluzole FDA LinkGeneric 07/2023
1	Neuroprotective AgentsIBA 07/2023
1	Excitatory Amino Acid AntagonistsIBA 07/2023
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 07/2023
1	Kainic Acid (Kainate)IBA 07/2023
1	Interferon-gamma (Interferon, gamma)IBA 03/2023
1	COVID-19 vaccine booster shotIBA 03/2023
1	Measles-Mumps-Rubella Vaccine (MMR Vaccine)IBA 01/2023
1	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2023
1	Pertussis VaccineIBA 01/2023
1	Dichlorodiphenyl Dichloroethylene (DDE)IBA 09/2022
1	insulin receptor-related receptor (IRR)IBA 03/2022
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2022
1	Therapeutic UsesIBA 01/2022
1	Amyloid (Amyloid Fibrils)IBA 01/2022
1	tau Proteins (tau Protein)IBA 01/2022
1	palmidrolIBA 01/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2021
1	regorafenibIBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	MethyltransferasesIBA 05/2016
1	Messenger RNA (mRNA)IBA 05/2016

2	Patient Admission (Patient Admissions) 06/2023 - 03/2022
1	Therapeutics 04/2021
1	Drug Therapy (Chemotherapy) 05/2016